Also trades as: 0J8P.L (LSE) · $vol 1M
IDXX NASDAQ
IDEXX Laboratories, Inc.
1W: +0.6%
1M: +6.1%
3M: -1.5%
YTD: -16.2%
1Y: -12.4%
3Y: +31.4%
5Y: -12.4%
$561.25
-8.96 (-1.57%)
Weekly Expected Move ±3.6%
$520
$540
$560
$581
$601
Credit Risk of going bust: lower than 88% of companies Debt: 2.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.50 (down 99.7%), IDEXX Laboratories, Inc. would be worth roughly what it owes.
Total debt $1.10B against a stock market value of $44.22B.
Distance to default 12.75 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $818.9M (short-term plus half of long-term), stock volatility 31.9%; Altman Z'' 10.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $1.50 (down 99.7%), IDEXX Laboratories, Inc. would be worth roughly what it owes.
Total debt $1.10B against a stock market value of $44.22B.
Distance to default 12.75 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $818.9M (short-term plus half of long-term), stock volatility 31.9%; Altman Z'' 10.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-11-06
Earliest Filing
2024-11-06
Latest Filing
supplier: 1
Counterparties (Filed by IDXX)
1 relationshipsCompanies named in IDXX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ortho-Clinical Diagnostics, Inc. | — | supplier | Supplier of dry slides for veterinary chemistry analyzers under amended supply agreements. | 2024-11-06 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-04 | Earnings Release; Exhibits | View | |
| 2026-05-15 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-03-26 | Officer/Director Change; Exhibits | View | |
| 2026-02-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-02-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-13 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-13 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-11-03 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-07 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-10 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-09 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-14 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-02-03 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-12-12 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-12-09 | Other Events; Financial Statements and Exhibits | View | |
| 2024-11-21 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-11-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR